GSK confirms former US CMO as new A/NZ chief
- 29 May, 2018 12:26
Garry Scarborough has been appointed Nortel's director of channels and alliances for Asia-Pacific
GSK has officially confirmed former US-based CMO, Theresa Agnew, as its area general manager for A/NZ to sit at the helm of its consumer healthcare business locally.
Agnew has been acting in the role for the past three months, relocating back to Australia from the US, where she was chief marketing officer and VP of US marketing. In the area GM position, she will oversee a range of well-known consumer brands including Panadol, Voltaren, Sensodyne, Polident and Otrivin. She officially takes up the post on 1 July.
Agnew has nearly 30 years’ experience in the consumer healthcare and medical devices industries. She kicked off her career at Johnson & Johnson, spending 21 years with the company, and has also held senior positions with LifeScan and McNeil consumer healthcare devices, plus DDB and Essilor International.
During her stint as CMO in the US, she was responsible for digital transformation across the US business as well as driving fresh growth. The work earnt her a mention as one of 18 marketing chiefs in the recent book, Global CMO: Best Practice in Marketing Effectiveness and Efficiency Around the World.
In a statement, GSK consumer healthcare regional head APAC, Filippo Lanzi, said Agnew had already made a big impact on the business since taken on the acting role in February.
“She has proven her commitment to the team and ability to help build the future of the A/NZ consumer healthcare business, with a focus on culture and development as well as building our brands,” he said.
Agnew said she’s looking forward to building a stronger foundation for the local group and generating sustainable growth.
“We have an outstanding team and market-leading brands and by partnering closely with our customers and industry, I believe we can have a positive impact on the health and well-being of our customers,” she said.